Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Tyler Knight,1 T Christopher Bond,1 Breanna Popelar,2 Li Wang,3 John W Niewoehner,4 Kathryn Anastassopoulos,1 Michael Philbin4 1Covance Market Access Services Inc., Gaithersburg, MD, 2Xcenda, LLC, Palm Harbor, FL, 3STATinMED Research, Ann Arbor, MI, 4Mallinckrodt, LLC, Hazelwood, MO, USA Ba...

Full description

Bibliographic Details
Main Authors: Knight T, Bond TC, Popelar B, Wang L, Niewoehner JW, Anastassopoulos K, Philbin M
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
dermatomyositis
polymyositis
medical resource use
repository adrenocorticotropic hormone
Online Access:https://www.dovepress.com/medical-resource-utilization-in-dermatomyositispolymyositis-patients-t-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/medical-resource-utilization-in-dermatomyositispolymyositis-patients-t-peer-reviewed-article-CEOR

Similar Items